Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Politics

Bipartisan senators’ bill would require Congress to approve new tariffs

by admin April 4, 2025
April 4, 2025
Bipartisan senators’ bill would require Congress to approve new tariffs

Two senior lawmakers have introduced a bipartisan bill that would reassert Congress’ powers over U.S. tariffs, a day after President Donald Trump announced a new wide-ranging tariff strategy during his ‘Liberation Day’ speech on Wednesday.

Sens. Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., on Thursday introduced the Trade Review Act of 2025, which would require the president to notify Congress about any new tariffs within 48 hours of imposition. 

The bill also requires that Trump provide an explanation of the rationale along with an analysis of the tariffs’ potential impact on the U.S. economy. Congress would have to approve the new tariffs within 60 days or allow them to expire.

If enacted, the bill would shift certain trade policymaking powers from the executive branch to the Congress. 

‘For too long, Congress has delegated its clear authority to regulate interstate and foreign commerce to the executive branch,’ Grassley, a Trump ally who is skeptical of tariffs, said in a statement. 

‘Building on my previous efforts as Finance Committee Chairman, I’m joining Senator Cantwell to introduce the bipartisan Trade Review Act of 2025 to reassert Congress’ constitutional role and ensure Congress has a voice in trade policy,’ he continued.

Cantwell said in a statement that Trump’s tariffs would hurt sectors such as agriculture, manufacturing and technology and have reverberating effects on consumers.

‘Ultimately, consumers will pay the price,’ Cantwell said in a statement. ‘It’s time for Congress to take action to counter the president’s trade war.’

Grassley’s home state of Iowa heavily relies on farm crop exports, while Cantwell’s Washington state is home to many export-heavy companies such as Boeing.

Trump on Thursday compared the tariffs to a medical operation, and said the ‘patient lived, and is healing.’ ‘The prognosis is that the patient will be far stronger, bigger, better, and more resilient than ever before,’ he wrote on Truth Social.

Thursday’s bill was introduced after four Republican senators joined Democrats in approving a separate resolution on Wednesday that would repeal Trump’s emergency declaration levying tariffs on Canadian imports. Grassley was not one of the Republican defectors. The resolution is likely dead on arrival in the House.

This post appeared first on FOX NEWS

previous post
Trump wants Musk to stay with administration, says DOGE found something ‘horrible’ today
next post
Here’s a closer look at Trump’s tariff plan: What to know about the new duties

Related Posts

‘Promises kept’: Trump signs executive order to ‘aggressively’...

February 19, 2025

Hegseth says US to boost ties with Philippines...

March 28, 2025

US military shoots down Houthi drones as Trump’s...

March 17, 2025

‘Ultra-right’: Trump budget chief pick Russell Vought faces...

January 23, 2025

‘Dead of night’: Dems accuse GOP of cowardice...

May 20, 2025

Judge denies embattled government-funded agency’s restraining order request...

March 20, 2025

4th round of US-Iran talks ends as Trump...

May 12, 2025

Reagan and Trump are more alike than you...

May 20, 2025

Trump promises to ramp up energy production, lower...

March 5, 2025

Funeral held for Shiri Bibas and her sons...

February 26, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 2

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 3

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 6

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 7

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved